Search - tctmd.com

Displaying 321 - 340 of 1325

Sort: Relevancy | Date

COLCOT Renews Hope for Anti-inflammatory Secondary Prevention

News Conference News AHA 2019

COLCOT Renews Hope for Anti-inflammatory in Secondary Prevention: Colchicine

Caitlin E. Cox

November 16, 2019

News Daily News

Women Face Greater Post-PCI Stroke Risk Than Men, Study Confirms

Caitlin E. Cox

November 15, 2019

News Daily News

FDA Advisors Recommend CVD Event Reduction Claim for Icosapent Ethyl

Michael O'Riordan

November 14, 2019

News Conference News AHA 2019

More Ischemia on Stress Echo Equals Greater Angina Benefit With PCI: ORBITA

Michael O'Riordan

November 14, 2019

News Conference News AHA 2019

LDL Levels Still Too High in Many Statin-Treated Patients: PINNACLE

Michael O'Riordan

November 13, 2019

News Opinion Off Script AHA 2019

Off Script: Will ISCHEMIA Answer Our Most Pressing Questions?

Ajay Kirtane, MD, SM

November 12, 2019

News Daily News

Noninvasive Tests for Chest Pain: New Insight Into Who Benefits Most

Yael L. Maxwell

November 07, 2019

News Daily News

Vasospasm, Microvascular Dysfunction Tied to MACE in Nonobstructive CAD

Michael O'Riordan

November 05, 2019

News Daily News

Women More Likely Than Men to Develop Heart Failure After STEMI

L.A. McKeown

November 04, 2019

News Conference News AHA 2019

ISCHEMIA Countdown Begins, but a ‘Black-and-White’ Answer Is Uncertain

Shelley Wood

October 25, 2019

News Daily News

Sex-Based Nuances Seen in iFR and FFR Testing: DEFINE-FLAIR

Caitlin E. Cox

October 24, 2019

News Daily News

Risk Prediction Model Personalizes Revascularization Options for FREEDOM-Like Patients

Michael O'Riordan

October 17, 2019

News Daily News

DAPT Cuts Saphenous Vein Graft Failure After CABG: Meta-analysis

Michael O'Riordan

October 17, 2019

News Daily News

Believing SCOT-HEART: New Analysis Probes Plausible Mechanisms of Benefit

Shelley Wood

October 14, 2019

News Opinion Off Script TCT 2019

Off Script: PCI of the Future? Let’s Break Down the Border Between Physiology and Anatomy

Kwan S. Lee

October 14, 2019

News Daily News

Recurrent Events Common Among Young Patients With CAD

Michael O'Riordan

October 11, 2019

News Conference News TCT 2019

PICCOLETO II: More Support for DCB Safety and Efficacy in Small Coronaries

L.A. McKeown

October 04, 2019

News Conference News TCT 2019

TICAKOREA: Ticagrelor Ups Bleeding Over Clopidogrel in Korean ACS Patients

Todd Neale

October 03, 2019

News Daily News TCT 2019

BLADE-PCI: Antirestenotic Drug Flops in Diabetics, but Inflammation Hypothesis Lives On

L.A. McKeown

October 02, 2019

News Conference News TCT 2019

FORZA: For Intermediate Lesions, OCT-Guided PCI Costs More, Yields Better Outcomes vs FFR

Caitlin E. Cox

October 01, 2019

Advertisement

COLCOT Renews Hope for Anti-inflammatory in Secondary Prevention: Colchicine

Women Face Greater Post-PCI Stroke Risk Than Men, Study Confirms

FDA Advisors Recommend CVD Event Reduction Claim for Icosapent Ethyl

More Ischemia on Stress Echo Equals Greater Angina Benefit With PCI: ORBITA

LDL Levels Still Too High in Many Statin-Treated Patients: PINNACLE

Off Script: Will ISCHEMIA Answer Our Most Pressing Questions?

Noninvasive Tests for Chest Pain: New Insight Into Who Benefits Most

Vasospasm, Microvascular Dysfunction Tied to MACE in Nonobstructive CAD

Women More Likely Than Men to Develop Heart Failure After STEMI

ISCHEMIA Countdown Begins, but a ‘Black-and-White’ Answer Is Uncertain

Sex-Based Nuances Seen in iFR and FFR Testing: DEFINE-FLAIR

Risk Prediction Model Personalizes Revascularization Options for FREEDOM-Like Patients

DAPT Cuts Saphenous Vein Graft Failure After CABG: Meta-analysis

Believing SCOT-HEART: New Analysis Probes Plausible Mechanisms of Benefit

Off Script: PCI of the Future? Let’s Break Down the Border Between Physiology and Anatomy

Recurrent Events Common Among Young Patients With CAD

PICCOLETO II: More Support for DCB Safety and Efficacy in Small Coronaries

TICAKOREA: Ticagrelor Ups Bleeding Over Clopidogrel in Korean ACS Patients

BLADE-PCI: Antirestenotic Drug Flops in Diabetics, but Inflammation Hypothesis Lives On

FORZA: For Intermediate Lesions, OCT-Guided PCI Costs More, Yields Better Outcomes vs FFR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content